What type of K+-channels antagonists should be administered for dementia treatment?

被引：0
|
作者：
Solntseva, E [1 ]
Bukanova, J [1 ]
机构：
[1] Russian Acad Med Sci, Inst Brain Res, Moscow, Russia
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 16 条
  • [1] Predicting changes in neuronal excitability type in response to genetic manipulations of K+-channels
    Marco Arieli Herrera-Valdez
    Sandra D Berger
    Carsten Duch
    Sharon Crook
    BMC Neuroscience, 10 (Suppl 1)
  • [2] For how long should the treatment with vitamin K antagonists be maintained?
    Schulman, S
    HAEMOSTASIS, 1999, 29 : 89 - 90
  • [3] PRODUCTS OF HEME-CATALYZED TRANSFORMATION OF THE ARACHIDONATE DERIVATIVE 12-HPETE OPEN S-TYPE K+-CHANNELS IN APLYSIA
    BELARDETTI, F
    CAMPBELL, WB
    FALCK, JR
    DEMONTIS, G
    ROSOLOWSKY, M
    NEURON, 1989, 3 (04) : 497 - 505
  • [4] Seminal vesicle invasion: What type of adjuvant treatment should be proposed?
    Bastide, C.
    Rossi, D.
    Salomon, L.
    Mouracade, P.
    Rozet, F.
    Cathelineau, X.
    Forgues, A.
    Roupret, M.
    Masson-Lecomte, A.
    Peyromaure, M.
    Rigaud, J.
    Larue, S.
    Pfister, C.
    Bonniol, R.
    Patard, J. J.
    Bessede, T.
    Staerman, F.
    Kamdoum, L.
    Soulie, M.
    Beauval, J. B.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E351 - E351
  • [5] ARE C-REACTIVE PROTEIN AND PROCALCITONIN EFFECTIVE BIOMARKERS FOR URINARY TRACT INFECTION IN ELDERLY PATIENTS? WHAT SHOULD BE ADMINISTERED FOR EMPIRICIAL TREATMENT?
    Iris, Nur Efe
    Gunver, Mehmet Guven
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2023, 26 (04): : 377 - 385
  • [6] Efficacy of short-term treatment with intravenously administered Ginkgo biloba special extract EGb 761 in Alzheimer type and vascular dementia
    Haase, J
    Halama, P
    Hoor, R
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 1996, 29 (04): : 302 - 309
  • [7] WHAT OBJECTIVE SHOULD BE ASSIGNED TO THE VARIOUS SUGGESTED TREATMENTS (NSAIDS, ANALGESICS, FUNDAMENTAL, PREVENTIVE OR CURATIVE TREATMENT) - WHAT TYPES OF PATIENTS SHOULD BE USED IN WHICH TYPE OF CLINICAL-TRIAL
    MENKES, CJ
    BARDIN, T
    DANGLAS, P
    REVUE DU RHUMATISME, 1990, 57 (9BIS): : S22 - S24
  • [8] The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
    Davies, Melanie
    Chatterjee, Sudesna
    Khunti, Kamlesh
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2016, 8 : 61 - 81
  • [9] Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
    Martinez, Felipe
    EUROPEAN CARDIOLOGY REVIEW, 2021, 16
  • [10] Openers of ATP-dependent K+-channels protect against a signal-transduction-linked and not freely reversible defect of insulin secretion in a rat islet transplantation model of Type 2 diabetes
    Björklund, A
    Hansen, JB
    Falkmer, S
    Grill, V
    DIABETOLOGIA, 2004, 47 (05) : 885 - 891
12